Clinical Trial Update: Protective Effect of N-acetylcysteine Against From Ototoxicity [Phase 2, Phase 3]

View source ↗

Summary

This update reports a Phase 2/Phase 3 trial evaluating whether N-acetylcysteine protects against ototoxic hearing loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hearing Loss

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: TC Erciyes University | Conditions: Hearing Loss, Extreme | Phase 2, Phase 3 | Status: COMPLETED